Veterinary Excipients Global Market Report 2024

The veterinary excipients market size has grown strongly in recent years. It will grow from $0.89 billion in 2023 to $0.94 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to advancements in veterinary medicine, rise pet healthcare expenditure, increased pet ownership, growth in demand for animal protein, and expansion of animal healthcare infrastructure.

The veterinary excipients market size is expected to see strong growth in the next few years. It will grow to $1.18 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The anticipated growth in the forecast period is linked to a heightened emphasis on animal welfare, a surge in pet insurance coverage, the increasing occurrence of zoonotic diseases, the expansion of the veterinary pharmaceuticals market, and the emergence of new excipients. Significant trends expected in this period include the adoption of personalized medicine for animals, the incorporation of natural and organic excipients, the integration of digital health solutions, ongoing innovation in the veterinary health sector, and advancements in technology.

The surge in zoonotic diseases is poised to drive the expansion of the veterinary excipients market in the future. Zoonotic diseases, which can be transmitted from animals to humans, are on the rise due to various factors including habitat encroachment, climate change, intensive farming, wildlife trade, deforestation, poor sanitation, and alterations in ecosystems, necessitating urgent intervention. Veterinary excipients play a crucial role in formulating medications aimed at treating zoonotic diseases, ensuring the stability, effectiveness, and safety of the active ingredients for animal health. For example, according to the European Union One Health, a food safety authority based in Italy, there was a more than 600% increase in locally acquired human West Nile virus infections, a mosquito-borne disease, in 2022 compared to 2021. Consequently, the surge in zoonotic diseases is propelling the growth of the veterinary excipients market.

Major companies in the veterinary excipients market are innovating by introducing products such as VitiPure excipients to meet the increasing demand for veterinary health solutions. VitiPure excipients are high-purity substances created to improve the stability and solubility of active pharmaceutical ingredients (APIs) in various applications. For example, Clariant, a specialty chemical company based in Switzerland, unveiled a range of VitiPure excipients in October 2023. These excipients provide versatile support for formulating APIs and administering them, even for delicate substances such as mRNA vaccines and biologics. One standout product is VitiPure O 80 Superior, a high-quality, low-microbial-load Polysorbate 80 known for its purity, colorless appearance, and lack of odor.

In August 2023, Domes Pharma Group, a pharmaceutical company based in France, completed the acquisition of Sentrx Animal Care Inc., for an undisclosed sum. This strategic move represents a notable advancement for Dômes Pharma in broadening its worldwide influence in veterinary ophthalmology and setting the groundwork for its therapeutic product lines in North America. SentrX Animal Care Inc., based in the United States, specializes in producing veterinary products, including veterinary excipients.

Major companies operating in the veterinary excipients market are Archer Daniels Midland Company, Badische Anilin- und Soda-Fabrik AG, Evonik Industries AG, DuPont de Nemours Inc., Clariant AG, Azelis India Private Limited, Lubrizol India Private Limited, Croda International Plc, Ashland Inc., JRS PHARMA GmbH & Co. KG, Vantage Specialty Chemicals, Colorcon Inc., Seppic SA, Spectrum Laboratory Products Inc., Gattefossé SAS, Quality Chemicals S.L., IOI Oleo GmbH, Lipoid LLC, Synergy API Private Limited, SSS Pharmachem Private Limited.

North America was the largest region in the veterinary excipients market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the veterinary excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary excipients refer to inert materials incorporated into the composition of veterinary drugs. These materials function as carriers or bases for the active components within the drug, facilitating manufacturing procedures and maintaining the medication's stability, absorption rate, and overall efficiency. Veterinary excipients play indispensable roles in animal medications, contributing significantly to their formulation, efficacy, safety, and practical application.

The primary chemical categories of veterinary excipients include polymers, alcohols, lipids, mineral salts, and others. Polymers are composed of large molecules consisting of repetitive structural units known as monomers, connected through covalent bonds. They serve multiple purposes in animals, including companion and production animals, such as fillers, binders, disintegrants, glidants, lubricants, bulking agents, buffering agents, tonicity adjusting agents, and preservatives. These applications span various uses, including biologics, pharmaceuticals, and medicated feed additives.

The veterinary excipients research report is one of a series of new reports that provides veterinary excipients market statistics, including the veterinary excipients industry's global market size, regional shares, competitors with a veterinary excipients market share, detailed veterinary excipients market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary excipients industry. This veterinary excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary excipients market consist of sales of humectants, antioxidants, solvents, and lipid-based excipients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.